Hardwyn India Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 10, 2025, 1:44 am

Competitors of Hardwyn India Ltd

All Competitor Stocks of Hardwyn India Ltd

Quarterly Result

Last Updated: August 19, 2025, 2:05 pm

Below is a detailed analysis of the quarterly data for Hardwyn India Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 31.95 Cr.. The value appears to be declining and may need further review. It has decreased from 36.30 Cr. (Mar 2025) to 31.95 Cr., marking a decrease of 4.35 Cr..
• For Expenses, as of Jun 2025, the value is 26.50 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 33.48 Cr. (Mar 2025) to 26.50 Cr., marking a decrease of 6.98 Cr..
• For Operating Profit, as of Jun 2025, the value is 5.45 Cr.. The value appears strong and on an upward trend. It has increased from 2.82 Cr. (Mar 2025) to 5.45 Cr., marking an increase of 2.63 Cr..
• For OPM %, as of Jun 2025, the value is 17.06%. The value appears strong and on an upward trend. It has increased from 7.77% (Mar 2025) to 17.06%, marking an increase of 9.29%.
• For Other Income, as of Jun 2025, the value is 0.05 Cr.. The value appears to be declining and may need further review. It has decreased from 0.36 Cr. (Mar 2025) to 0.05 Cr., marking a decrease of 0.31 Cr..
• For Interest, as of Jun 2025, the value is 0.17 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.28 Cr. (Mar 2025) to 0.17 Cr., marking a decrease of 0.11 Cr..
• For Depreciation, as of Jun 2025, the value is 0.38 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.42 Cr. (Mar 2025) to 0.38 Cr., marking a decrease of 0.04 Cr..
• For Profit before tax, as of Jun 2025, the value is 4.95 Cr.. The value appears strong and on an upward trend. It has increased from 2.48 Cr. (Mar 2025) to 4.95 Cr., marking an increase of 2.47 Cr..
• For Tax %, as of Jun 2025, the value is 29.09%. The value appears to be improving (decreasing) as expected. It has decreased from 30.24% (Mar 2025) to 29.09%, marking a decrease of 1.15%.
• For Net Profit, as of Jun 2025, the value is 3.51 Cr.. The value appears strong and on an upward trend. It has increased from 1.74 Cr. (Mar 2025) to 3.51 Cr., marking an increase of 1.77 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.07. The value appears strong and on an upward trend. It has increased from 0.04 (Mar 2025) to 0.07, marking an increase of 0.03.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 12:59 pm

Balance Sheet

Last Updated: July 25, 2025, 1:08 pm

Below is a detailed analysis of the balance sheet data for Hardwyn India Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 49.00 Cr.. The value appears strong and on an upward trend. It has increased from 35.00 Cr. (Mar 2024) to 49.00 Cr., marking an increase of 14.00 Cr..
• For Reserves, as of Mar 2025, the value is 344.00 Cr.. The value appears to be declining and may need further review. It has decreased from 347.00 Cr. (Mar 2024) to 344.00 Cr., marking a decrease of 3.00 Cr..
• For Borrowings, as of Mar 2025, the value is 10.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 9.00 Cr. (Mar 2024) to 10.00 Cr., marking an increase of 1.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 47.00 Cr.. The value appears to be improving (decreasing). It has decreased from 52.00 Cr. (Mar 2024) to 47.00 Cr., marking a decrease of 5.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 449.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 443.00 Cr. (Mar 2024) to 449.00 Cr., marking an increase of 6.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5.00 Cr. (Mar 2024) to 4.00 Cr., marking a decrease of 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 348.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 348.00 Cr..
• For Other Assets, as of Mar 2025, the value is 97.00 Cr.. The value appears strong and on an upward trend. It has increased from 90.00 Cr. (Mar 2024) to 97.00 Cr., marking an increase of 7.00 Cr..
• For Total Assets, as of Mar 2025, the value is 449.00 Cr.. The value appears strong and on an upward trend. It has increased from 443.00 Cr. (Mar 2024) to 449.00 Cr., marking an increase of 6.00 Cr..

Notably, the Reserves (344.00 Cr.) exceed the Borrowings (10.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Hardwyn India Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 5. It has decreased from 0.29 (Mar 24) to 0.23, marking a decrease of 0.06.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.23. This value is below the healthy minimum of 5. It has decreased from 0.29 (Mar 24) to 0.23, marking a decrease of 0.06.
• For Cash EPS (Rs.), as of Mar 25, the value is 0.26. This value is below the healthy minimum of 3. It has decreased from 0.32 (Mar 24) to 0.26, marking a decrease of 0.06.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 8.05. It has decreased from 10.96 (Mar 24) to 8.05, marking a decrease of 2.91.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 8.05. It has decreased from 10.96 (Mar 24) to 8.05, marking a decrease of 2.91.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 3.78. It has decreased from 4.38 (Mar 24) to 3.78, marking a decrease of 0.60.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 0.38. This value is below the healthy minimum of 2. It has decreased from 0.48 (Mar 24) to 0.38, marking a decrease of 0.10.
• For PBIT / Share (Rs.), as of Mar 25, the value is 0.34. This value is within the healthy range. It has decreased from 0.45 (Mar 24) to 0.34, marking a decrease of 0.11.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.32. This value is within the healthy range. It has decreased from 0.41 (Mar 24) to 0.32, marking a decrease of 0.09.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.22. This value is below the healthy minimum of 2. It has decreased from 0.29 (Mar 24) to 0.22, marking a decrease of 0.07.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.22. This value is below the healthy minimum of 2. It has decreased from 0.29 (Mar 24) to 0.22, marking a decrease of 0.07.
• For PBDIT Margin (%), as of Mar 25, the value is 10.18. This value is within the healthy range. It has decreased from 11.10 (Mar 24) to 10.18, marking a decrease of 0.92.
• For PBIT Margin (%), as of Mar 25, the value is 9.23. This value is below the healthy minimum of 10. It has decreased from 10.31 (Mar 24) to 9.23, marking a decrease of 1.08.
• For PBT Margin (%), as of Mar 25, the value is 8.58. This value is below the healthy minimum of 10. It has decreased from 9.55 (Mar 24) to 8.58, marking a decrease of 0.97.
• For Net Profit Margin (%), as of Mar 25, the value is 6.08. This value is within the healthy range. It has decreased from 6.69 (Mar 24) to 6.08, marking a decrease of 0.61.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 6.08. This value is below the healthy minimum of 8. It has decreased from 6.69 (Mar 24) to 6.08, marking a decrease of 0.61.
• For Return on Networth / Equity (%), as of Mar 25, the value is 2.85. This value is below the healthy minimum of 15. It has increased from 2.67 (Mar 24) to 2.85, marking an increase of 0.18.
• For Return on Capital Employeed (%), as of Mar 25, the value is 4.27. This value is below the healthy minimum of 10. It has increased from 4.06 (Mar 24) to 4.27, marking an increase of 0.21.
• For Return On Assets (%), as of Mar 25, the value is 2.41. This value is below the healthy minimum of 5. It has increased from 2.29 (Mar 24) to 2.41, marking an increase of 0.12.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.02. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.02.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.40. It has increased from 0.35 (Mar 24) to 0.40, marking an increase of 0.05.
• For Current Ratio (X), as of Mar 25, the value is 1.73. This value is within the healthy range. It has increased from 1.65 (Mar 24) to 1.73, marking an increase of 0.08.
• For Quick Ratio (X), as of Mar 25, the value is 0.84. This value is below the healthy minimum of 1. It has increased from 0.78 (Mar 24) to 0.84, marking an increase of 0.06.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.09. This value is below the healthy minimum of 4. It has increased from 0.08 (Mar 24) to 0.09, marking an increase of 0.01.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 15.68. This value is within the healthy range. It has increased from 14.49 (Mar 24) to 15.68, marking an increase of 1.19.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 10.36. This value is within the healthy range. It has increased from 9.73 (Mar 24) to 10.36, marking an increase of 0.63.
• For Enterprise Value (Cr.), as of Mar 25, the value is 564.80. It has decreased from 1,175.70 (Mar 24) to 564.80, marking a decrease of 610.90.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.06. This value exceeds the healthy maximum of 3. It has decreased from 7.69 (Mar 24) to 3.06, marking a decrease of 4.63.
• For EV / EBITDA (X), as of Mar 25, the value is 30.03. This value exceeds the healthy maximum of 15. It has decreased from 69.24 (Mar 24) to 30.03, marking a decrease of 39.21.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.99. This value is within the healthy range. It has decreased from 7.62 (Mar 24) to 2.99, marking a decrease of 4.63.
• For Price / BV (X), as of Mar 25, the value is 1.40. This value is within the healthy range. It has decreased from 3.04 (Mar 24) to 1.40, marking a decrease of 1.64.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.99. This value is within the healthy range. It has decreased from 7.62 (Mar 24) to 2.99, marking a decrease of 4.63.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness